Clinical Trials

MedNews is a FREE SERVICE of Medical and Pharma Insider in conjunction with BCI News Service.

To have your company news featured at Medical and Pharma Insider, please visit www.bcinewsservice.com.

View our disclaimer/disclosure

Featuring MedNews and MedTalks Videos, video conversations with management of medical, pharma, biopharma, healthcare, telemedicine, and medical device companies.

Mar 4
3 min

Prana Thoracic raises $3 million to advance its lung tissue excision tool for lung cancer

Prana Thoracic is developing the first minimally invasive, lung-sparing device for early intervention of suspicious pulmonary nodules.

Mar 2
6 min

Mitsubishi Tanabe Pharma America announces preliminary results from Phase 3 ALS Trial

RADICAVA is administered in 28-day cycles by IV infusion for ALS.

Feb 24
5 min

Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million

. While various psychedelics have demonstrated promise for the treatment of PTSD, Transcend focuses on a psychoactive compound that may...

Feb 13
2 min

Quotient Sciences expands its early-phase formulation development capabilities for oral dosage forms

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services

Feb 1
4 min

Panbela prices $15 million public offering

CPP-1X (eflornithine) is being developed as a single agent tablet or high dose power sachet for several indications including prevention...

Jan 18
2 min

To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab

The company seeks to achieve U.S. regulatory approval for Bentracimab within the first-half of 2024.

Jan 4
3 min

Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea

Enrollment for the clinical trials is expected to begin in the second quarter of 2023

Dec 27, 2022
2 min

Ablaze Pharmaceuticals and Yonghe Pharma to develop targeted radiopharma therapies

Under the agreement. Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze...

Dec 22, 2022
4 min

University Hospitals Performs First Arthroscopic Surgeries in Ohio using ArthroFree Wireless Camera

Lazurite‘s ArthroFree is the first wireless surgical camera system to receive market clearance from the U.S. Food and Drug Administration...

Nov 23, 2022
3 min

scPharmaceuticals Announces Pricing of $50 Million Public Offering

scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential...

Nov 5, 2022
3 min

H.I.G. Capital acquires leading global clinical research organization Celerion

Headquartered in Lincoln, NE, Celerion is a leading global clinical research organization focused on providing end-to-end early stage clinic

Oct 15, 2022
4 min

Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development

The company is focused on innovative targeted radiopharmaceuticals for the diagnosis, monitoring, and therapy of cancer.

Oct 8, 2022
4 min

RadioMedix raises $40 million to advance its alpha therapy platform for oncology

Targeted alpha therapies are currently considered one of the most advanced technologies available to treat patients with incurable cancers.

Oct 2, 2022
4 min

CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus

“EpiSmart has the potential to be a game-changer for the treatment for keratoconus.

Sep 28, 2022
3 min

Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome

Aqualung is an early-stage biotech company developing immune-focused therapeutic platform, eNamptor™.

Sep 27, 2022
2 min

SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects

Our team is addressing two core issues with our proprietary technology: enhancing bioavailability and reducing development time.

Sep 1, 2022
3 min

OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease

OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) is a life sciences and biotechnology company recently listed on Nasdaq .

Aug 13, 2022
2 min

Clario invests in new technology to reduce translation times for clinical trials

For nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials.

Aug 5, 2022
2 min

Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

Immunis’ FDA Phase 1/2a clinical trial is a study to assess IMM01-STEM in elderly participants with muscle atrophy.

Aug 3, 2022
3 min

IDRx raises $122 million to transform cancer treatment with precision combination therapies

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies.